These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. [Multicenter evaluation of a new local antihistaminic drug (levocabastine)]. Bischoff P; Gerber M Klin Monbl Augenheilkd; 1992 May; 200(5):354-7. PubMed ID: 1351957 [TBL] [Abstract][Full Text] [Related]
46. Topical cyclosporine 0.5 per cent and preservative-free ketorolac tromethamine 0.5 per cent in vernal keratoconjunctivitis. Kosrirukvongs P; Luengchaichawange C J Med Assoc Thai; 2004 Feb; 87(2):190-7. PubMed ID: 15061303 [TBL] [Abstract][Full Text] [Related]
47. Onset of action, effectiveness and tolerance of levocabastine and nedocromil in topical therapy of seasonal allergic rhinoconjunctivitis. The Deutsche Rhinitis-Studiengruppe. Kremer B; Tündermann A; Goldschmidt O Arzneimittelforschung; 1998 Sep; 48(9):924-30. PubMed ID: 9793620 [TBL] [Abstract][Full Text] [Related]
48. [Local treatment with diclofenac-Na eyedrops in diseases of the anterior eye segment]. van Husen H Klin Monbl Augenheilkd; 1986 Jun; 188(6):615-9. PubMed ID: 3761968 [TBL] [Abstract][Full Text] [Related]
49. Safety and efficacy of lodoxamide in vernal keratoconjunctivitis. Das D; Khan M; Gul A; Alam R J Pak Med Assoc; 2011 Mar; 61(3):239-41. PubMed ID: 21465936 [TBL] [Abstract][Full Text] [Related]
50. Ophthalmic levocabastine for allergic conjunctivitis. Med Lett Drugs Ther; 1994 Apr; 36(920):35-6. PubMed ID: 7908401 [No Abstract] [Full Text] [Related]
51. [Allergic conjunctivitis from cellular involvement to medical practice]. Nicodin A Oftalmologia; 2007; 51(2):96-9. PubMed ID: 17937044 [TBL] [Abstract][Full Text] [Related]
52. Epinastine in the management of ocular allergic disease. Friedlaender MH Int Ophthalmol Clin; 2006; 46(4):85-6. PubMed ID: 17060794 [No Abstract] [Full Text] [Related]
53. Lodoxamide treatment of allergic conjunctivitis. Cerqueti PM; Ricca V; Tosca MA; Buscaglia S; Ciprandi G Int Arch Allergy Immunol; 1994 Oct; 105(2):185-9. PubMed ID: 7920019 [TBL] [Abstract][Full Text] [Related]
54. Management of severe allergic conjunctivitis with topical cyclosporin a 0.05% eyedrops. Ozcan AA; Ersoz TR; Dulger E Cornea; 2007 Oct; 26(9):1035-8. PubMed ID: 17893529 [TBL] [Abstract][Full Text] [Related]
55. [Clinical experimentation with a new antihistaminic molecule in allergic conjunctivitis]. Hesse A; Reggiardo F; Satragno L; Rivara A Minerva Med; 1988 Oct; 79(10):883-6. PubMed ID: 2903466 [TBL] [Abstract][Full Text] [Related]
56. Ocular allergy: diagnosis and treatment. Butrus S; Portela R Ophthalmol Clin North Am; 2005 Dec; 18(4):485-92, v. PubMed ID: 16314214 [TBL] [Abstract][Full Text] [Related]
57. Efficacy of lodoxamide eye drops on tear fluid cytology of patients with vernal conjunctivitis. Oguz H; Bitiren M; Aslan OS; Ozardali I Acta Med Okayama; 1999 Jun; 53(3):123-6. PubMed ID: 10410789 [TBL] [Abstract][Full Text] [Related]
58. [First Hungarian report of olopatadine eyedrop therapy in children and adults suffering from seasonal allergic conjunctivitis]. Endre L; Hidasi V Orv Hetil; 2006 Sep; 147(36):1741-3. PubMed ID: 17087018 [TBL] [Abstract][Full Text] [Related]
59. [Clinical efficacy and safety of levocarbastine++ in the therapy in children suffering from seasonal allergic rhinitis and conjunctivitis who are less than 12 year of age]. Kurzawa R; Kossek M; Doniec Z; Mazurek H; Urbanek E; Sak-Kopytyńska I; Radliński J; Bukowczan Z Pol Merkur Lekarski; 1998 May; 4(23):269-72. PubMed ID: 9825660 [TBL] [Abstract][Full Text] [Related]